TRANSGENE has a total of 37 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 1990. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are REFLECTION BIOTECHNOLOGIES LTD, BARNETT SUSAN W and BERNA BIOTECH AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Australia | 7 | |
#3 | Canada | 6 | |
#4 | United States | 5 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Israel | 3 | |
#7 | Japan | 2 | |
#8 | Brazil | 1 | |
#9 | France | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Enzymes | |
#7 | Unspecified technologies | |
#8 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Erbs Philippe | 9 |
#2 | Jund Richard | 6 |
#3 | Silvestre Nathalie | 5 |
#4 | Remy Christelle | 5 |
#5 | Thioudellet Christine | 5 |
#6 | Rittner Karola | 5 |
#7 | Grellier Benoît | 4 |
#8 | Balloul Jean-Marc | 4 |
#9 | Lacoste Jerome | 3 |
#10 | Acres Bruce | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021053207A1 | Combination of a poxvirus encoding hpv polypeptides and il-2 with an anti-pd-l1 antibody | |
WO2020011754A1 | Chimeric vaccinia viruses | |
WO2019170820A1 | Parapoxvirus vectors | |
AU2003246073A1 | Mutant having uracil phosphoribosyl transferase activity | |
CA2473570A1 | Antisense compounds directed against human csf-1 | |
FR2669931A1 | New variants derived from interferons-alpha and their production process. |